2018 annual financial data
Skye Bioscience 2018 Operating cash flow growth
Direct answer
Operating cash flow growth was -19.55%.
Operating income was -4,693,000 USD and net income was -19,194,000 USD.
Operating cash flow was -3,943,014 USD.
Get free Skye Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,693,000 USD
- Net income
- -19,194,000 USD
- Operating cash flow
- -3,943,014 USD